Recently, the FDA declared that these shortages are over, which means compounding pharmacies are no longer allowed to make these medications on a regular basis. This change has left many people in an undesirable position and wondering what they should do. Today, we are going to answer some questions about these changes and talk about some exceptions and alternatives that you may find helpful.
When Did Making Compounded GLP-1 Drugs Stop?
Even though lawsuits were brought by some industry groups like the Outsourcing Facilities Association (OFA) to block the FDA’s decision, a federal court has upheld the FDA’s authority to enforce these deadlines, and the grace periods have all expired.
| Medication | Pharmacy Type | Compounding Must Stop By |
|---|---|---|
| Tirzepatide | State-licensed pharmacies (503A) | February 18, 2025 |
| Outsourcing facilities (503B) | March 19, 2025 | |
| Semaglutide | State-licensed pharmacies (503A) | April 22, 2025 |
| Outsourcing facilities (503B) | May 22, 2025 |
What Is Behind the Compounded Semaglutide & Tirzepatide Ban?
The FDA’s official reason for banning compounded versions of semaglutide and tirzepatide is patient safety and the increased availability of the name-brand drugs, but it is hard to ignore that money and market control play a big role in this decision as well.
There is no question that drugmakers like Novo Nordisk (Ozempic, Wegovy) and Eli Lilly (Mounjaro, Zepbound) have much to gain from shutting down their competition.
According to the FDA
- The ban is based on safety laws under the Drug Supply Chain Security Act and the Food, Drug, and Cosmetic Act.
- Compounding is only allowed when there is a clinical need and the original drug is on the FDA’s shortage list. Semaglutide was added to the shortage list in August 2022, and tirzepatide was added in December 2022.
- Once the supply returned and shortages were resolved, compounding no longer met the legal criteria. Semaglutide was taken off the shortage list in February 2025, and tirzepatide in October 2024.
- Some compounding pharmacies were also using semaglutide sodium or acetate, which was not approved for injection in humans. This gave the FDA more reason to intervene and ensure patient safety.
A Threat to Big Profits
- Novo Nordisk and Eli Lilly lobbied hard for this ban because they want full control over the pricing and distribution of these popular weight loss drugs.
- Novo and Eli Lilly make billions of dollars from these drugs. Every compounded dose was money out of their pockets.
- By forcing people to use the brand-name drug only, they regain their monopoly pricing power.
- Compounded versions cost much less and allowed people who could not afford brand-name versions to get the help they needed to lose weight.
Is the Compounded Ban for Safety or Monopoly?
The truth is, it is about both. There were some valid safety concerns with some compounders cutting corners or using non-standard ingredients and threatening patient safety.
But the timing and pressure from drug companies make it clear this move also protects their profits, and many people see the FDA’s enforcement as favoring Big Pharma over patients, especially those who cannot afford the steep cost of the name-brand medication each month.
If all the compounded versions had stayed high-quality and safe, and if there were real competition in pricing, this ban probably would not have happened so fast. But with billions of dollars at stake, the monopoly argument is definitely part of the story.
How to Get Compounded Semaglutide and Tirzepatide
Pure copies of these FDA-approved injections are no longer legally compounded since the deadlines have passed, but some compounding pharmacies and telehealth platforms are offering customized versions that may differ in dosage or form and include additives like vitamin B12 to qualify as “clinically different” and bypass the ban.
Your Doctor States a Compound Is Medically Necessary
In some cases, a doctor can still prescribe a compounded version if the brand-name drug does not offer a dosage or the form that meets your medical needs. But it has to follow strict rules.
The FDA does allow compounding only if:
- The compounded drug is “clinically different” from the brand-name version, like you need a lower dose, an oral form instead of an injection, or you are allergic to an ingredient in the branded drug (like preservatives).
- Your doctor writes a specific prescription saying why the compounded version is medically necessary and clearly documents exactly how and why the compounded form is different and required for your care.
- Unfortunately, you cannot get a compounded copy just because it is cheaper or easier to get, but if you have justification, like you need a special dosage like 0.25 mg weekly and the brand only starts at 0.5 mg, a compounding pharmacy might make that lower dose if the doctor clearly states the medical reason and writes it into the prescription. The same rules apply for people who cannot tolerate injections and need an oral or sublingual form of the medication.
FAQs About Compounded Semaglutide & Tirzepatide Going Away
When will compounded semaglutide be banned?
Cutoff dates for obtaining compounded semaglutide were April 22, 2025, and May 22, 2025, so unfortunately, unless you have a special circumstance, you will not be able to get a new prescription for compounded semaglutide.
Will doctors prescribe compounded semaglutide?
Only in special circumstances otherwise; they will need to switch to FDA‑approved options.
Can I switch from compounded semaglutide to Wegovy?
Yes, your doctor can easily transition you to brand-name Wegovy or Ozempic, as compounded versions are no longer available.
Is semaglutide and tirzepatide getting banned?
No, only compounding these prescription medications is being stopped, not the drugs themselves. FDA-approved brand versions remain legal and available with a doctor-issued prescription.
Are You Looking For GLP-1 Medication?
Reveal Weight Loss is here to help you find a weight loss solution that actually works for your body, your lifestyle, and your goals. If you are a good candidate for GLP-1 medication, their knowledgeable team of experts will walk you through your options and help you find the best fit for your needs and your budget. They understand that one size does not fit all when it comes to weight loss strategies, and they will work with you every step of the way to create a plan that is realistic, safe, and designed to help you achieve sustainable weight loss. Set up your consultation today and get your journey to better health started.
